Biotech / Pharmaceutical
Quantisweb™ for the BioTech and Pharma Industry by MDM Technologies
Workplan 208.4 – Problem to resolve: Production line speed reduced to prevent capping and picking of pharmaceutical tablet.
Search for proper combination of ingredients and processes to increase speed of production line. Ingredient names where removed to protect any sensitive information. The reader will find quadratic, square and cubic equations in the Behavioral Laws Report.
View PDF document
MDM Technologies markets a patented revolutionary tool for product development and production improvement "Quantisweb™".
The Quantisweb approach is synthetic and global, and not, analytical and sequential. Using the analytical and sequential approach, the number of possible experiments is increased exponentially with the number of variables or parameters. For example, when considering 5 parameters, a full factorial study requires 243 experiments, with the same example Quantisweb’s synthetic and global approach reduces the number of laboratory experiments to 6 experiments or Np+1 experiments, where Np is the number of ingredients and/or processes. This requires a novel approach to solving a problem. First you define the desired product characteristics, input a ratio of importance amongst these characteristics and the necessary ingredients and/or processes including any physical chemical or resource constraints to create the product. Quantisweb is capable of elucidating the combinations of 100 characteristics with up to 3 levels of consideration and 25 ingredients and processes. Quantisweb eliminates the guesswork by computing the optimal values for each ingredient/process simultaneously. Read more..
Drug Research and Development
Research indicates that the vast majority of drugs at best work in 30 to 50 per cent of people.
Furthermore, side effects and toxicity are a significant issue with many promising drugs.
Using the current practice, predetermining patient profiles for treatment is limited. Trial and
error is the mainstay of drug therapies. If one drug does not work then another may.
When one mixes multiple drugs to address the multiple symptoms of a patient, with this
approach it is difficult to generate specific drug therapies achieving high efficacy with limited
to no side effects and toxicity. The future is patient specific drug therapies to achieve high
efficacy and success. Read more..